Since estrogen deficiency leads to a mitochondrial biogenesis defect, overexpression of PGC-1α to increase mitochondrial biogenesis is a potential strategy to treat mitochondrial diseases (Srivastava et al., 2009). This evidence concerns the gene PPARGC1A and mitochondrial disease.